ASMI welcomes new head of Therapeutic Goods Administration

02 May 2012

Return to Media Release Index

The Australian Self-Medication Industry (ASMI), the industry body representing non-prescription consumer healthcare products, today welcomed the announcement of Dr John Skerritt as the new National Manager of the Therapeutic Goods Administration (TGA).

The Executive Director of ASMI, Dr Deon Schoombie, said Dr Skerritt brings a formidable background in the medical, regulatory and research fields, and is well qualified to oversee the work of the TGA.

"We are delighted to have someone of Dr Skerritt's background taking over in this very important position, at a time when the TGA has a number of key initiatives and reviews underway in both the OTC and complementary medicines area.

"We congratulate Dr Skerritt on this appointment and look forward to working with him and his team," Dr Schoombie said.

Dr Skerritt is currently the Deputy Secretary of the Department of Primary Industries in the Victorian Government. He holds a PhD in Pharmacology and is an adjunct Professor at the University of Queensland.

Issues that are central to ASMI and which will be pursued with the TGA over coming months include measures to provide IP protection for OTC and complementary medicines, a review of business processes for OTC medicines (OTC BPR), sensible complementary medicines reform and establishing a best practice regulatory agency under the proposed joint agency (ANZTPA).
___________________________________________________________________________
About ASMI: The Australian Self-Medication Industry (ASMI) is the peak industry body for the Australian self care industry representing consumer healthcare products including over-the-counter medicines and complementary medicines. ASMI's mission is to promote better health through responsible self-care. This means ensuring that safe and effective self-care products are readily available to all Australians at a reasonable cost. ASMI works to encourage responsible use by consumers and an increasing role for cost-effective self-medication products as part of the broad national health strategy. www.asmi.com.au

Media contact: Bob Bowden, Foresight Communications (02) 9241 2811, 0412 753 298